Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris: Results from the APSIS study

This publication has 43 references indexed in Scilit:

• Platelet aggregability in vivo is attenuated byverapamil but not bymetoprolol in patients with stable angina pectoris
  The American Journal of Cardiology, 1995
• Intraindividual variability of fibrinogen levels and cardiovascular risk profile.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
  The Lancet, 1993
• Influence of platelet size on outcome after myocardial infarction
  The Lancet, 1991
• Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
  New England Journal of Medicine, 1990
• A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors
  American Heart Journal, 1988
• Fibrinogen and risk of cardiovascular disease. The Framingham Study
  JAMA, 1987
• Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death
  New England Journal of Medicine, 1984
• Essential hypertension. The behaviour of the haemorheological determinants and their trends during beta-blocker treatment.
  Japanese Heart Journal, 1983
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980